Joris De Maeyer, a veteran pharma-biotech expert with over 15 years of experience, has wielded his vision and leadership to steer innovative R&D programs across various management and executive roles. As a former Investment Director at Bioqube Ventures and Chief Scientific Officer at Facio Therapies, he has consistently provided expert guidance in program strategy, execution, and funding. Notably, his expertise spans critical assessment and validation of novel opportunities, building project strategies that focus on unique selling points, reviewing target and disease areas, and structuring of fund raising materials and investment proposals. Joris has also excelled in leading collaborative and integrated R&D programs, identifying and integrating essential R&D disciplines to advance R&D projects, developing partnerships with academic institutions, and monitoring research studies with utmost attention.

With such an excellent track record of experience, knowledge, and leadership, Joris De Maeyer is a seasoned professional whose acumen surpasses the pharma-biotech industry's borders.